Cargando…
A Prognostic Analysis of Male Breast Cancer (MBC) Compared with Post-Menopausal Female Breast Cancer (FBC)
BACKGROUND: Male breast cancer (MBC) is known to be rare compared with female breast cancer (FBC) and to account for only 1% of all breast cancers. To date, male patients diagnosed with breast cancer are normally treated based on the guidelines for FBC. Specifically, studies have found that diagnosi...
Autores principales: | Yu, Xing-Fei, Yang, Hong-Jian, Yu, Yang, Zou, De-Hong, Miao, Lu-Lu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4551848/ https://www.ncbi.nlm.nih.gov/pubmed/26313461 http://dx.doi.org/10.1371/journal.pone.0136670 |
Ejemplares similares
-
Adjuvant tamoxifen for male breast cancer (MBC).
por: Ribeiro, G., et al.
Publicado: (1992) -
Landscape of HER2-low metastatic breast cancer (MBC): results from the Austrian AGMT_MBC-Registry
por: Gampenrieder, Simon Peter, et al.
Publicado: (2021) -
Advancements in the Treatment of Metastatic Breast Cancer (MBC): The Role of Ixabepilone
por: Cristofanilli, Massimo
Publicado: (2012) -
Clinical features and prognostic factors of male breast cancer vs. female breast cancer
por: Sang, Guo, et al.
Publicado: (2021) -
The potential of FBC fly ashes to reduce CO(2) emissions
por: Uliasz-Bocheńczyk, Alicja, et al.
Publicado: (2020)